Position in HALO
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$93,140
+$25,603 QoQ
Shares Held
1,190
+13.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#518
of 660 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST HORIZON CORP holds $7,150,431 across 40 Biotechnology names. HALO ranks #6 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,201 | $5,563,871 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
615 | $383,476 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
2,161 | $122,765 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
487 | $119,202 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
297 | $93,877 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
1,190 | $93,140 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,088 | $88,682 | |
| 8 | INSM |
INSMED Inc
|
708 | $75,486 |
All Filings in HALO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,140 | 1,190 | Shares | Defined | 2026-07-20 | |
| 2026-03-31 | $67,537 | 1,045 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $82,307 | 1,223 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $56,471 | 770 | Shares | Defined | 2025-10-27 | |
| No filing history on record for this holder in this stock. | ||||||